Patents by Inventor Joachim E. Goring

Joachim E. Goring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Xanthine derivatives and their use in pharmaceutical compositions
    Patent number: 4454138
    Abstract: Compounds of the formula (II): ##STR1## wherein: X is sulphur and Y is oxygen or sulphur;R.sub.1 is an alkyl group of up to 6 carbon atoms;R.sub.2 is an alkyl group of up to 6 carbon atoms; andn is 1; orX is oxygen and Y is sulphur; one of R.sub.1 and R.sub.2 is an alkyl group of up to 6 carbon atoms and the other is an alkyl group of 2 to 6 carbon atoms; andn is 1 or 2, having useful pharmacological activity, pro-drugs therefor, a process for their preparation, pharmaceutical compositions containing said compounds or pro-drugs, and intermediates in their preparation of the compounds.
    Type: Grant
    Filed: April 29, 1982
    Date of Patent: June 12, 1984
    Assignee: Johann A. Wuelfing
    Inventor: Joachim E. Goring
  • Xanthine derivatives, and their use in pharmaceutical compositions
    Patent number: 4451449
    Abstract: Ketals of 1-(1,3-dialkylxanthin-7-yl)propan-2-ones are of use in the treatment of vascular disorders. A representative embodiment is 2-methyl-2-(1,3-dibutylxanthin-7-ylmethyl)-1,3-dioxalane.
    Type: Grant
    Filed: June 29, 1981
    Date of Patent: May 29, 1984
    Assignee: Johanna Wuelfing
    Inventor: Joachim E. Goring
  • 1-(5-Oxohexyl)-3-alkyl-7-(2-oxopropyl)xanthines
    Patent number: 4372959
    Abstract: Compounds of the formula (I): ##STR1## wherein R is C.sub.1-4 alkyl, pharmaceutical compositions containing them and a process for their preparation. The compounds are useful for the treatment of peripheral vascular diseases in mammals.
    Type: Grant
    Filed: June 17, 1981
    Date of Patent: February 8, 1983
    Assignee: Beecham-Wulfing GmbH & Co. KG
    Inventor: Joachim E. Goring
  • Pharmaceutical compositions
    Patent number: 4256750
    Abstract: It has been found that 1,3-di-n-butyl-7-(2-oxopropyl)xanthine is a particularly effective agent for increasing oxygen partial pressure and contractility in ischaemic and skeletal muscle. Pharmaceutical compositions containing 1 to 30 mg of this agent are described.
    Type: Grant
    Filed: December 11, 1979
    Date of Patent: March 17, 1981
    Assignee: Johann A. Wulfing
    Inventors: Joachim E. Goring, Peter P. Ochlich
  • Pharmaceutical composition containing a xanthine derivative
    Patent number: 4225607
    Abstract: It has been found that 1,3-di-n-butyl-7-(2-oxopropyl)xanthine is a particularly effective agent for increasing oxygen partial pressure and contractility in ischaemic and skeletal muscle. Pharmaceutical compositions containing 1 to 30 mg of this agent are described.
    Type: Grant
    Filed: May 14, 1979
    Date of Patent: September 30, 1980
    Assignee: Johann A. Wulfing
    Inventors: Joachim E. Goring, Peter P. Ochlich